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Fucosyllactoses (2′- or 3′-FL) account for up to 20% of human milk oligosaccharides
(HMOs). Infant bifidobacteria, such as Bifidobacterium longum subsp. infantis, utilize the
lactose moiety to form lactate and acetate, and metabolize L-fucose to 1,2-propanediol
(1,2-PD). Eubacterium hallii is a common member of the adult gut microbiota that can
produce butyrate from lactate and acetate, and convert 1,2-PD to propionate. Recently, a
Swiss cohort study identified E. hallii as one of the first butyrate producers in the infant gut.
However, the global prevalence of E. hallii and its role in utilization of HMO degradation
intermediates remains unexplored. Fecal 16S rRNA gene libraries (n = 857) of humans
of all age groups from Venezuela, Malawi, Switzerland, and the USA were screened
for the occurrence of E. hallii. Single and co-culture experiments of B. longum subsp.
infantis and E. hallii were conducted in modified YCFA containing acetate and glucose,
L-fucose, or FL. Bifidobacterium spp. (n = 56) of different origin were screened for the
ability to metabolize L-fucose. Relative abundance of E. hallii was low (10−5–10−3%)
during the first months but increased and reached adult levels (0.01–10%) at 5–10
years of age in all four populations. In single culture, B. longum subsp. infantis grew
in the presence of all three carbohydrates while E. hallii was metabolically active only
with glucose. In co-culture E. hallii also grew with L-fucose or FL. In co-cultures grown
with glucose, acetate, and glucose were consumed and nearly equimolar proportions
of formate and butyrate were formed. B. longum subsp. infantis used L-fucose and
produced 1,2-PD, acetate and formate in a ratio of 1:1:1, while 1,2-PD was used by
E. hallii to form propionate. E. hallii consumed acetate, lactate and 1,2-PD released by
B. longum subsp. infantis from FL, and produced butyrate, propionate, and formate.
Beside B. longum subsp. infantis, Bifidobacterium breve, and a strain of B. longum
subsp. suis were able to utilize L-fucose. This study identified a trophic interaction of
infant bifidobacteria and E. hallii during L-fucose degradation, and pointed at E. hallii
as a metabolically versatile species that occurs in infants and utilizes intermediates of
bifidobacterial HMO fermentation.
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INTRODUCTION
Human milk oligosaccharides (HMOs) are one of the
major glycan source of the infant gut microbiota. Primary
components of HMOs are D-glucose, D-galactose, L-fucose,
N-acetylglucosamine, and sialic acid. Lactose constitutes the
reducing end of HMOs, its galactose moiety can be fucosylated
or sialylated to form 2′- or 3′-fucosyllactose (2′-FL or 3′-FL),
or 3′- and 6′-sialyl-lactose (3′-SL or 6′-SL). Lactose can also be
elongated with units of N-acetyllactosamine (Gal-β1-4GlcNAc)
with its simplest form being Lacto-N-neotetraose (LNnT) (Kunz
et al., 2000). The composition of HMOs is individually different
and remains stable during different lactation phases (Niñonuevo
et al., 2008; de Leoz et al., 2012). FLs can account for up to 20%
of all HMOs (Niñonuevo et al., 2008; de Leoz et al., 2012).
Infant bifidobacteria species, such as Bifidobacterium longum
subsp. infantis and Bifidobacterium bifidum, are adapted to
degrade HMOs (LoCascio et al., 2010; Rockova et al., 2012;
Turroni et al., 2014) and constitute a big proportion of the
infant intestinal microbiota immediately after birth (Avershina
et al., 2013; Jost et al., 2014). The degradation of HMOs relies
on a complex network of extracellular solute binding proteins,
transporters, and intra- or extracellular glycosyl hydrolases (GH).
B. longum subsp. infantis carries out intracellular degradation
while B. bifidum metabolizes HMOs extracellularly (Garrido
et al., 2015). Both B. longum subsp. infantis and B. bifidum possess
several α-fucosidases that release L-fucose from FL (Sela et al.,
2012; Garrido et al., 2015). L-fucose can then be either used by the
strain itself or can be released for bacterial cross-feeding (Garrido
et al., 2015; Bunesova et al., 2016).
L-fucose is a desoxyhexose that is a common component of
many N- and O-linked glycans and of glycolipids produced by
mammalian cells (Becker and Lowe, 2003). L-fucose utilization
has been investigated in depth in pathogens such as Escherichia
coli, Shigella spp. and Bacillus cereus (Staib and Fuchs, 2014).
These bacteria employ a fucose isomerase FucI, a fucose aldolase
FucA, and a fucose kinase FucK to form L-lactaldehyde which can
be further metabolized to 1,2-propanediol (1,2-PD). Recently,
we could show that strains of B. longum subsp. infantis and B.
longum subsp. suis metabolize L-fucose to 1,2-PD presumably
by a pathway that employs non-phosphorylated intermediates
similar to Campylobacter andXanthomonas spp. (Bunesova et al.,
2016). Genes related to L-fucose degradation were located on two
genomic regions, one is part of the HMO degradation cluster
H1 of B. longum subsp. infantis DSM 20088 (LoCascio et al.,
2010), while region 2 contained a gene encoding a putative fucose
permease (Bunesova et al., 2016).
In the intestine, 1,2-PD is a precursor of propionate by
a pathway that employs a glycerol/diol dehydratase as a key
enzyme (Reichardt et al., 2014). The frequent detection of genes
encoding glycerol/diol dehydratases in fecal metagenomes of
adults suggested that 1,2-PD conversion significantly contributes
to intestinal propionate formation (Reichardt et al., 2014; Engels
et al., 2016). One species with the ability to convert 1,2-PD to
propionate is Eubacterium hallii which is a common commensal
in adults (Engels et al., 2016). E. hallii formed similar amounts
of propionate in the presence or absence of glucose and did not
utilize glucose if 1,2-PD was present (Engels et al., 2016). E. hallii
can also grow and form butyrate using either glucose, or acetate
and lactate as substrates (Duncan et al., 2004).
We hypothesized that a trophic interaction between E. hallii
and B. longum subsp. infantis can yield short chain fatty acids
(SCFAs) butyrate or propionate from lactate and acetate, or from
1,2-PD, respectively. Both butyrate and propionate are important
for gut microbiota/host homeostasis as they interact with the
host epithelium and impact the immune system. Butyrate is a
main energy source of colonocytes, impacts cell proliferation
and differentiation, and lowers the risk of colitis and colorectal
cancer (Wong et al., 2006; Plöger et al., 2012). Propionate acts
as a precursor for gluconeogenesis in the liver and also impacts
cell differentiation with potential health-promoting impact on
intestinal inflammation, and cancer development (Reichardt
et al., 2014).
Bifidobacterium is the predominant genus of the gut
microbiota of breast fed infants. Little data exists on the
occurrence of E. hallii in early life. Recently, a Swiss cohort study
identified E. hallii as one of the first butyrate producers in the
infant gut (Pham et al., 2016). However, the global prevalence of
E. hallii and its role in the metabolism of L-fucose sourced from
HMOs remains unexplored.
It was therefore the aim of this study to investigate the
occurrence and abundance of E. hallii in populations of
different age and origin, and to prove trophic interactions of
E. hallii and B. longum subsp. infantis during growth in the
presence of glucose, L-fucose, and FL. We also screened further
Bifidobacterium spp. and strains (n = 56) to investigate whether
species other B. longum subsp. infantis or subsp. suis are able to
metabolize L-fucose.
METHODS
Bacterial Strains and Culture Conditions
E. hallii DSM 3353 obtained from the Deutsche Sammlung
von Mikroorganismen und Zellkulturen (DSMZ) was cultivated
in modified YCFA medium (mYCFA) containing 30 mM
acetate as described by Duncan et al. (2004) with slight
modifications (Table 1). All components except L-cysteine-HCL
(Sigma-Aldrich) were solubilized in deionized water, and pH
was adjusted to pH 7.6 with NaOH. The medium was flushed
with CO2 and boiled. When the color changed from blue to
pink, L-cysteine-HCl (0.01%, w/v) was added. The medium
was transferred to Hungate tubes flushed with CO2, and tubes
were sealed and autoclaved. Stab cultures of E. hallii that were
frozen at −20◦C in mYCFA agar (1.5% (w/v) agar) were used
as stock cultures. For each experiment, a fresh agar stock
was thawed; 1 ml of liquid YCFA medium was added and
thoroughly shaken before being transferred to 8 ml liquid
mYCFA medium. After incubation at 37◦C for 24 h, the culture
was transferred at least once to fresh mYCFA broth before the
experiment. Bifidobacterium spp. (Table 2) were obtained from
the culture collections of the Laboratory of Food Biotechnology
of ETH Zurich, the Department of Microbiology, Nutrition, and
Dietetics, of the Czech University of Life Sciences Prague, or
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TABLE 1 | mYCFA medium composition.
Component Addition
Amicase 1% (w/v)
Yeast extract 0.25% (w/v)
Sodium bicarbonate 0.5% (w/v)
Glucose (replaced with L-fucose and FL) 1% (w/v)
Mineral solution [3% (w/v) potassium dihydrogen phosphate, 6%
(w/v) sodium chloride, 0.6% (w/v) magnesium sulfate, 0.6%
calcium chloride (w/v)]
15% (v/v)
Vitamin solution [0.01% (w/v) biotin, 0.01 (w/v) cobalamin, 0.03%
p-aminobenzoic acid (w/v), 0.05% folic acid (w/v), 0.15%
pyridoxamine (w/v)]
0.1% (v/v)
Volatile fatty acid mix [56.6% (v/v) acetic acid, 20% (v/v) butyric
acid, 13.3% (v/v) propionic acid]
0.31% (v/v)
Hemin (0.5mg ml−1 ) 0.02%
Resazurin (1mg ml−1 ) 0.1%
L-cysteine hydrochloride monohydrate 0.1%
from DSMZ. Stock cultures of bifidobacteria were maintained
at −80◦C in 30% glycerol. To prepare working cultures,
bifidobacteria were streaked on Wilkens–Chalgren medium
(Oxoid) supplied with soya peptone (5 g L−1, Biolife, WCSP),
Tween 80 (1 mL L−1, Sigma-Aldrich), and fresh, filter-sterilized
L-cysteine-HCl (0.5 g L−1). Single colonies were picked and
were grown in liquid WCSP supplied with fresh, filter-sterilized
L-cysteine-HCl (0.5 g L−1) at 37◦C for 24 h. For preparation
of co-culture experiments, 100 µL of B. longum subsp. infantis
overnight culture grown liquid WCSP were added to mYCFA
medium, and the culture was incubated at 37◦C for 24 h. Unless
otherwise stated, mYCFA containing 55 mM glucose was used to
routinely cultivate E. hallii and B. longum subsp. infantis.
Single and Co-Culture Studies in the
Presence of Different Substrates
Growth kinetics were assessed in mYCFA medium supplied with
glucose (50 mM, mYCFA_glc, Sigma-Aldrich), L-fucose (40 mM,
mYCFA_fuc, Sigma-Aldrich), or FL (6 mM 2′-FL and 6 mM 3′-
FL, mYCFA_FL, Glycom A/S). Trace amounts of glucose were
added to mYCFA_fuc to enforce initial growth (Bunesova et al.,
2016). Hungate tubes containing 9 ml mYCFA_glc, mYCFA_fuc,
or mYFA_FL were inoculated with overnight cultures of E. hallii
and B. longum subsp. infantis (0.25 mL each). For comparison,
E. hallii and B. longum subsp. infantis were also grown in single
cultures. Samples were taken after 0, 4, 8, 12, 24, and 48 h
of incubation for substrate and metabolite analysis, and for
DNA isolation. Bacterial growth was evaluated by measuring
the optical density at 600 nm (OD600). Additionally, 16S
rRNA gene copies of E. hallii and B. longum subsp. infantis
were determined in the co-cultures as outlined below. Growth
was investigated in at least independent triplicates with the
exception of B. longum subsp. infantis growth in mYCFA_glc
and mYCFA_fuc, which was only investigated in duplicates.
Therefore, standard deviations are not shown in the respective
graphs.
Screening of Bifidobacteria Strains for
L-Fucose Utilization
Overnight bifidobacteria cultures grown in liquid WCSP were
washed and resuspended in phosphate buffered saline (PBS).
Bifidobacteria (50 µL) were inoculated in 950 µL API medium
supplied fresh, filter-sterilized L-cysteine-HCl (0.5 g L−1) and
with 30 mM glucose, or with 30 mM L-fucose and trace amounts
of glucose. Cultures were incubated at 37◦C for 48 h. Growth and
utilization of the carbohydrate source was judged by color change
of the medium from blue to yellow. For selected strains, L-fucose
utilization and metabolite formation were assessed by HLPC-RI
as outlined below.
Analysis of Substrate Utilization and
Metabolite Formation
Glucose and L-fucose consumption, and the formation of 1,2-PD,
lactate, acetate, formate, butyrate, and propionate was measured
using high performance liquid chromatography (Merck-Hitachi)
equipped with an Aminex HPX-87H column (300 × 7.8 mm;
BioRad) and a refractive index detector (HPLC-RI). Samples
were centrifuged at 13,000 g for 5 min at 4◦C. Supernatants (40
µL injection volume) were eluted with 10 mM H2SO4 at a flow
rate of 0.6 ml min−1 at 40◦C. Sugars, SCFAs, 1,2-PD, and lactate
(all Sigma-Aldrich) were quantified using external standards.
Propanal and propanol were quantified with ion
chromatography with pulsed amperometric detection (IC-
PAD) on a ICS-5000+ system (Thermo Scientific) equipped
with a quaternary gradient pump, a thermoautosampler, and
an electrochemical detector with a cell containing an Ag/AgCl
reference electrode and a disposable thin-film platinum working
electrode tempered at 25◦C. Analytes were separated on a
IonPac ICE-AS1 4 × 250 mm ion-exclusion column with guard
column (Thermo Scientific) operated at 30◦C using isocratic
conditions (0.1 M methanesulfonic acid; 0.2 mL min−1) for 36
min. The injection volume was 10 µL. Electrochemical data
was obtained using a triple potential waveform consisting of
regeneration/detection, oxidation, and reduction potentials:
E1 = 0.3 V (t1 = 0.31 s), E2 = 1.25 V (t2 = 0.34 s, tint = 0.02
s), E3 = −0.4 V (t3 = 0.39 s). Currents were measured and
integrated with respect to time (tint). Propanal and propanol
(Sigma-Aldrich) were quantified using external standards.
DNA Isolation and Quantification E. hallii
and B. longum subsp. Infantis in Infant
Feces and in Co-Cultivation Studies
Genomic DNA was isolated from 0.5 mL fermented mYCFA
using the FastDNA SPINKit for Soil (MP Biomedicals). Genomic
DNA from stool samples (n = 368) collected as part of an infant
cohort study, and of Swiss children and adult had been isolated as
described before (Vanderhaeghen et al., 2015; Pham et al., 2016).
The abundance of E. hallii was determined using primers EhalF
(5′- GCGTAGGTGGCAGTGCAA -3′) and EhalR (5′- GCACCG
RAGCCTATACGG-3′) (Ramirez-Farias et al., 2009). B. longum
subsp. infantis was quantified using primer pair F (5′-TCGCGT
CYGGTGTGAAAG-3′), and R (5′-CCACATCCAGCRTCCAC-
3′) (Rinttilä et al., 2004). Primers Eub338F (5′-ACTCCTACG
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TABLE 2 | L-fucose utilization and 1,2-PD formation of strains of bifidobacteria.
Species Strain code Origin L-fucose utilization 1,2-PD formation
B. breve DSM 20213 Intestine of infant + nd
TPY 10-1 Kenyan infant feces, 6m + +
BSM 1-2 Kenyan infant feces, 6m + +
TPY 5-1 Kenyan infant feces, 6m + +
N4-BM5-i12 Swiss mother breast-milk + +
N4-NF3-i1 Swiss infant feces, 1 w + +
N4-NF3-i3 Swiss infant feces, 1 w + +
N4-NF4-i1 Swiss infant feces, 2 w + +
BR03 Probiotic drops + nd
OL2 Czech infant feces, 10 w + nd
TA1 Czech infant feces, 10 w + nd
B. longum subsp. infantis DSM 20088 Intestine of infant + +
DSM 20090 Intestine of infant + nd
BRS 8-2 Kenyan infant feces, 6m + nd
TPY 12-1 Kenyan infant feces, 6m + +
TPY 8-1 Kenyan infant feces, 6m − −
BV BIOPRON probiotic product + nd
B. longum subsp. longum DSM 20219 Intestine of adult − −
TA2 Czech infant feces, 10 w − −
N2-MF1-i1 Swiss adult feces − −
N18-MF4-i8 Swiss adult feces − −
2ToBifN Czech infant feces − −
MA2 Czech infant feces − −
BL13 Czech adult feces − −
B. longum subsp. suis DSM 20211 Pig feces − −
5/9 Calf feces − −
022II Calf feces − −
BSM 11-5 Kenyan infant feces, 6m + +
B. kashiwanohense DSM 21854 Infant feces, 1.5 y old − −
PV 20-2 Kenyan infant feces, 6m − −
TPY11-1 Kenyan infant feces, 6m − −
B. bifidum DSM 20456 Feces breast fed infant − −
DSM 20239 Feces breast fed infant − −
DSM 20082 Adult feces − −
DSM 20215 Adult feces − −
BRS 26-2 Kenyan infant feces, 6m − −
BSM 28-1 Kenyan infant feces, 6m − −
BRS300 Kenyan infant feces, 6m − −
B. thermophilum RBL67 Infant feces − −
B. animalis subsp. lactis N1-MF3-i7 Intestine of adult − −
B. adolescentis JK3 Czech infant feces, 3 w − −
JK10 Czech adult feces − −
JK17 Czech adult feces − −
1MBif Czech adult feces − −
B. catenulatum DSM 16992 Human feces − −
20ToBifN Czech infant feces − −
10VoBif Czech infant feces − −
B. pseudocatenulatum N18-NF4-i5 Swiss infant feces, 1m − −
B. dentium DSM 20436 Dental caries − −
VBif10D2 Czech infant feces − −
B. angulatum DSM 20098 Human feces − −
(Continued)
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TABLE 2 | Continued
Species Strain code Origin L-fucose utilization 1,2-PD formation
B. minimum DSM 20102 Sewage − −
B. pseudolongum subsp. pseudolongum DSM 20099 Pig feces − −
DSM 20095 Chicken feces − −
B. pseudolongum subsp. globosum DSM 20092 Rumen − −
PV8-2 Kenyan infant feces, 6m − −
Utilization was tested in API medium supplied with 5 g L-1 L-fucose and trace amounts of glucose. Color shift of the API medium after 48 h of incubation indicated L-fucose utilization
(+). 1,2-PD formation was verified by HPLC-RI for selected samples (Table 3). nd, not determined; m, months; w, weeks.
GGAGGCAGCAG-3′) and Eub518R (5′- ATTACCGCGGCT
GCTGG-3′) were employed to quantify total bacteria 16S rRNA
genes (Fierer et al., 2005). Reactions were performed using a 7500
Fast Real-Time PCR System (Applied Biosystems) and the Kapa
SYBR FAST qPCR mastermix (Biolab Scientifics Instruments
SA). Thermal cycling started with an initial denaturation step at
95◦C for 3 min, followed by 40 cycles consisting of denaturation
at 95◦C for 3 s, annealing at 60◦C for 10 s, and elongation at
72◦C for 25 s. To verify specificity of amplification, melting curve
analysis and agarose gel electrophoresis for amplicon size control
were performed. To generate standards, PCR amplicons were
cloned into PGEMT Easy Vector and heterologously expressed
in E. coli according to instructions of the supplier (Promega).
Standard curves were prepared from ten-fold dilutions of
linearized plasmids harboring the 16S rRNA gene of interest.
Linear detection range was between, log 2.3 and log 8.3 gene
copies for E. hallii 16S rRNA genes, between log 2.9 and log
8.9 gene copies bifidobacteria 16S rRNA genes, and between
log 3.0 and log 8.0 gene copies for total bacteria 16S rRNA
genes. A factor of 5.5 and 4 for Eubacterium spp. and B. longum
subsp. infantis, (rrnDB, http://rrndb.mmg.msu.edu; Veˇtrovský
and Baldrian, 2013), respectively, was applied to calculate the
numbers of cells accounting for several 16S rRNA gene copies per
genome.
16s rRNA Gene Amplicon Libraries Screens
16S rRNA gene sequencing datasets published by Yatsunenko
et al. (2012) were downloaded from MG-RAST (MG-RAST ID
401). The 489 datasets with known age of the donor contained
in total 1.0∗109 sequences and on average 2.1∗106 sequences.
All reads were aligned against the Silva database (version 123.1,
Quast et al., 2013) using MALT in semiglobal alignment mode
(Herbig et al., 2016) and only matches with a percent identity
>97% were reported. Alignments were then used to assign reads
on the Silva taxonomy. A read was placed on the lowest taxon so
that at least 90% of the alignments were covered by that taxon
(majority vote 90%). Unaligned reads were extracted and placed
on the Silva taxonomy by using the rdp classifier with a cutoff
of 0.8.
Identification of L-Fucose Utilization
Related Genes in B. breve Genomes
Genomes of Bifidobacterium breve DSM 20213 (PRJDB57) and
UCC 2003 (CP000303.1) were screened for genes encoding
proteins related to L-fucose metabolism using BlastP and the
corresponding proteins of B. longum subsp. infantis DSM 20088
region 1 and 2 for the query (Bunesova et al., 2016, see also
below).
Screening of Shotgun Sequencing
Datasets for Presence of Proteins
Encoding L-Fucose Utilization Regions 1
and 2
Metagenomic datasets (n = 111) published by Yatsunenko et al.
(2012) were downloaded from MG-RAST (MG-RAST ID 98).
The datasets contained in total 16,318,166 sequences and on
average 147,010 sequences per sample. The smallest and largest
datasets contained 19,587 and 478,588 sequences, respectively,
with an average sequence length of 358 bases. All datasets were
aligned using DIAMOND blastx in sensitive mode (Buchfink
et al., 2015) against a modified bacterial RefSeq database (Pruitt
et al., 2007). The modified RefSeq database was composed by
adding 24 protein sequences of B. longum subsp. infantis DSM
20088 and B. breve DSM 20213 fucose utilization regions 1 and 2
(Bunesova et al., 2016, WP_003830405.1, WP_003830403.1,
WP_003830401.1, WP_003830400.1, WP_065457149.1,
WP_014484327.1, WP_003829769.1, WP_003829768.1,
WP_025300063.1, WP_013141362.1, WP_003829764.1,
WP_012578562.1, WP_012578563.1, WP_012578564.1,
WP_012578565.1, WP_012578566.1, WP_012578567.1,
WP_012578568.1, WP_013141357.1, WP_012578533.1,
WP_012578534.1, WP_012578535.1, WP_012578536.1,
WP_012578537.1) to the standard RefSeq database. Reads
were assigned to the best aligning protein sequences which had
a bitscore >50. Reads assigned to the 24 proteins sequences of
interest were reported.
Statistical Analysis
A sigmoidal non-linear regression model [Weibull, 5 Parameter
model, f = if(x<=x0-b∗ln(2)∧(1/c); y0; y0+a∗(1-exp(-(abs(x-
x0+b∗ln(2)∧(1/c))/b)∧c))) implemented in SigmaPlot 13, Systat
Software] was chosen to fit curves to log% abundance data of
E. hallii in the different populations. Student’s paired t-test with
two-tailed distribution was used to identify significant differences
in metabolite formation, OD600 nm, and cell counts between
treatments. A p < 0.05 was considered significant.
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RESULTS
Age and Geographical-Dependent
Occurrence of E. hallii
We screened 489 previously obtained 16S rRNA gene amplicon
libraries from Malawi, Venezuela and USA (Yatsunenko et al.,
2012) for the occurrence of E. hallii. Concurrently, we
determined E. hallii relative abundance in a Swiss infant cohort
study which followed the fecal microbiota of 40 infants for
the first 2 years of life (Pham et al., 2016) using qPCR, and
compared to Swiss teenagers and Swiss adults (Vanderhaeghen
et al., 2015; together n = 368; Figure 1). Minimum detection
limits were ∼10−4 and 10−5% relative abundance for 16S rRNA
gene libraries and qPCR screenings, respectively.
In populations fromVenezuela, the USA, andMalawi, E. hallii
occurred in all infant samples of 1 year of age or younger
FIGURE 1 | Global occurrence of E. hallii. (A) Log % abundance of E. hallii in populations from USA, Malawi and Venezuela extracted from 16S rRNA gene
amplicon libraries (Yatsunenko et al., 2012) (n = 489). (B) Log% abundance of E. hallii in feces of donors of different age groups from Switzerland (n = 348). A
sigmoidal non-linear regression model was chosen to fit curves to log % abundance data of E. hallii in the different populations.
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at means of log −2.0 ± 1.2, −2.9 ± 1.0, and −2.9 ± 0.8%,
respectively (Figure 1A). Relative abundance increased after 1–
1.5 years in donors from Venezuela (100% occurrence), the
USA (95% occurrence), and Malawi (100%). In Swiss infants,
occurrence levels of E. hallii fluctuated between 13 and 40%
until 1 year, and increased to 85% at 2 years of age (log −2.9 ±
0.8%; Figure 1B). Between 5 and 10 years, relative abundance of
E. hallii reached adult levels in all four populations (Malawi: log
−0.4± 0.3%, Venezuela: log−0.2± 0.3%, USA: log−0.1± 0.6%,
Switzerland: log 0.8± 0.5%).
Growth of E. hallii and B. longum subsp.
Infantis in Single- and Co-Cultures
To investigate trophic interactions between B. longum subsp.
infantis and E. hallii in the presence of glucose, L-fucose and FL,
B. longum subsp. infantis, and E. hallii were grown in single- and
co-cultures in mYCFA.
In single culture, B. longum subsp. infantis reached a final
optical density (OD600 nm 1.9) in the presence of glucose, and a
lower maximal OD600 nm when grown with L-fucose and FL (1.5
± 0.1 and 1.5, respectively) after 48 h of incubation (Figure 2A).
In mYCFA_glc −25.6 mM glucose was used, and 55.4, 9.9, and
13.1 mM acetate, lactate, and formate were formed (Figure 2D).
In mYCFA_fuc, B. longum subsp. infantis used −28.3 ± 2.8 mM
L-fucose and produced nearly equimolar amounts of 1,2-PD,
acetate and formate (25.5 ± 4.8, 22.4 ± 1.0, and 26.7 ± 0.5 mM,
respectively; Figure 2G). Lactate was produced at low amounts
(2.0 ± 1.0 mM), and mean carbon recovery was 86%. In the
presence of FL, B. longum subsp. infantis formed acetate (33.6
mM), lactate (16.8 mM), 1,2-PD (7.8 mM), and low amounts of
formate (3.1 mM; Figure 2J).
In single culture, E. hallii grew rapidly to OD 600 nm of 1.7
± 0.2 after 12 h of incubation in mYCFA_glc (Figure 2B).
From 1mol glucose and 0.5mol acetate, ∼1mol butyrate and
0.5mol formate were produced (Figure 2E). Maximum optical
density in mYCFA_FL and mYCFA_fuc was significantly lower
than with glucose with OD600 nm 0.9 and 0.5 after 12 and 9 h
of incubation, respectively (Figure 2B). With L-fucose and FL,
E. hallii formed 2.7± 1.0 and 6.0± 1.1 mM butyrate, respectively
(Figures 2H,K). No acetate utilization and formate production
were detected.
For the co-cultures, qPCR was used in addition to optical
density measurements to monitor the growth of both strains
(Figure 3). Cell counts were calculated based on 16S rRNA genes
corrected for several 16S rRNA gene copies per genome. In
mYCFA_glc, cell counts of both strains increased by log 2.8
cells ml−1 during the first 8 h of incubation, after which growth
slowed down (Figure 3A). Highest OD600 nm was reached after
24 h of incubation (Figure 2C). The amount of acetate used, and
butyrate and formate formed in the co-cultures was similar to E.
hallii single cultures (Figure 2F), and only low amounts of lactate
(0.6± 0.7 mM) were detected after 48 h (Figure 2F).
Co-cultures grown in mYCFA_fuc reached a maximum OD
of 1.1± 0.1 after 48 h of incubation (Figure 2C). During the first
12 h, B. longum subsp. infantis and E. hallii grew exponentially
with increased cell counts of log 3 and log 2.7 cells mL−1,
respectively (Figure 3B). In co-cultures, B. longum subsp. infantis
utilized only ∼35% of L-fucose compared to single cultures
(10.4 ± 8 mM). The co-cultures formed propionate (8.2 ± 3.5
mM), butyrate (7.4 ± 0.8 mM), and formate (10.9 ± 1.7 mM;
Figure 2I). Butyrate formed by the co-cultures was significantly
(p < 0.05) higher compared to butyrate formation of E. hallii
single culture in mYCFA_fuc (7.4 ± 0.8 vs. 2.7 ± 1.0 mM).
1,2-PD, propanal, and propanol were not detected during co-
culture fermentations, and there was no apparent accumulation
or consumption of acetate or lactate (Figure 2I).
When grown in co-cultures in mYCFA_FL, cell counts of
B. longum subsp. infantis and E. hallii increased by 3.2 and 2.8 log
during the first 8 h of incubation (Figure 3C), and maximal OD
was reached after 24 h of incubation (Figure 2C). Acetate (18.2
± 1.6 mM), propionate (9.7 ± 5.1 mM), and butyrate (5.4 ± 3.1
mM), and formate (19.7 ± 5.0 mM) were detected after 48 h of
incubation (Figure 2L). 1,2-PD and lactate were only present at
low levels <1 mM.
Bifidobacterium Production of 1,2-PD from
L-Fucose
To investigate whether L-fucose utilization was a trait limited to
B. longum subsp. infantis, or was also present in other infant-,
adult-, or animal-associated bifidobacteria, we screened n = 56
Bifidobacterium strains (Table 2) for growth in API medium
supplied with 30 mM L-fucose and trace amounts of glucose. All
isolates were capable of growing in API medium supplied with 30
mM glucose indicating the suitability of the assay. Only strains of
B. longum subsp. infantis and subsp. suis, and of B. breve were
identified as being able to metabolize L-fucose and to form 1,2-
PD. L-fucose was used and 1,2-PD was formed in a ratio of ∼1:1
by all L-fucose-utilizing strains (Table 3). Additionally, lactate,
acetate, and formate were produced leading to carbon recoveries
between 87 and 109% (Table 3).
Genes Related to L-Fucose Utilization in
B. breve Genomes
We previously identified two genomic regions that encompass
genes potentially involved in L-fucose utilization of strains
of B. longum subsp. infantis and B. longum subsp. suis
(Bunesova et al., 2016). The genome of B. breve DSM 20213
(PRJDB57) possessed a set of genes with slightly differing genome
organization to B. longum subsp. infantis and B. longum subsp.
suis (Figure 4). Region 1 encompassed a gene encoding an
α-fucosidase (GH family 95) with 78% homology in 607/783
AA to BLON_2335 of B. longum subsp. infantis DSM 20088.
Region 1 also contained genes encoding a putative L-fuconate
dehydratase (96% homology in 284/293 AA to B. longum
subsp. infantis DSM 20088 L-fuconate dehydratase, region 1),
a L-fucose dehydrogenase (93% homology in 245/262 AA,
region 1), L-fuconolactone hydrolase (50% homology in 132/264
AA, region 2), and a 4-hydroxy-tetrahydrodipicolinate synthase
(89% homology in 265/296 AA, region 1). B. breve region 2
contained another L-fuconate dehydratase (97% homology in
417/426 AA, region 2), L-fucose dehydrogenase (94% homology
in 249/263 AA, region 2), a putative fucose permease (62%
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FIGURE 2 | Growth, substrate utilization, and metabolite formation of E. hallii and B. longum subsp. infantis in single and co-culture. Optical density
(OD600nm) of B. longum subsp. infantis (A), E. hallii (B), and the B. longum subsp. infantis / E. hallii co-culture (C) during growth in modified YCFA supplied with
glucose, L-fucose or FL. Substrate utilization and metabolite formation of B. longum subsp. infantis (D,G,J), E. hallii (E,H,K), and the B. longum subsp. infantis / E.
hallii co-culture (F,I,L) in mYCFA supplied with glucose (D–F), L-fucose (G–I), or FL (J–L).
Frontiers in Microbiology | www.frontiersin.org 8 January 2017 | Volume 8 | Article 95
Schwab et al. Trophic Interactions during L-Fucose and Fucosyllactose Degradation
FIGURE 3 | Cell counts of B. longum subsp. infantis and E. hallii during growth in co-culture. Cell counts of B. longum subsp. infantis and E. hallii during
growth in co-culture in mYCFA_glc (A), mYCFA_fuc (B), and mYCFA_FL (C).
TABLE 3 | Substrate utilization, metabolite formation and carbon recovery.
Substrate consumption (mM) Metabolite production (mM) Carbon recovery (%)
Species ID L-fucose Lactate Formate Acetate 1,2-PD
B. breve TPY 10-1 −14.9 ± 4.5 10.2 ± 5.2 6.3 ± 6.0 9.2 ± 6.7 13.8 ± 4.0 109
BSM 1-2 −8.5 ± 1.1 5.3 ± 4.4 4.2 ± 3.0 3.1 ± 2.0 9.3 ± 1.3 105
TPY 5-1 −12.7 ± 0.5 6.5 ± 2.3 5.4 ± 0.9 6.5 ± 4.1 11.4 ± 1.4 94
N4-BM5-i12 −8.3 ± 3.9 4.6 ± 2.5 4.0 ± 0.5 2.5 ± 3.4 6.8 ± 1.9 87
N4-NF3-i1 −11.7 ± 3.1 7.2 ± 1.5 6.6 ± 6.7 5.5 ± 5.0 11.2 ± 2.8 99
N4-NF3-i3 −5.9 ± 1.4 6.1 ± 1.5 0.6 ± 1.1 1.4 ± 0.9 5.7 ± 1.7 102
B. longum subsp. infantis DSM 20088 −3.9 ± 0.7 3.8 ± 0.4 −0.1 ± 0.2 0.8 ± 1.4 3.9 ± 0.8 109
TPY 12-1 −3.8 ± 1.5 1.4 ± 0.5 1.2 ± 1.1 1.6 ± 0.3 3.8 ± 1.1 91
B. longum subsp. Suis BSM 11-5 −11.5 ± 1.0 5.8 ± 1.4 4.8 ± 4.2 3.3 ± 0.9 11.2 ± 1.3 91
L-fucose utilization and lactate, formate, acetate, and 1,2-PD formation of selected bifidobacteria in API medium supplied with 30 mM L-fucose and trace amounts of glucose after 48
h of incubation at 37◦C.
homology in 262/461 AA, region 2), a L-fuconolactone hydrolase
(96% homology in 246/255 AA, region 2), and a 4-hydroxy-
tetrahydrodipicolinate synthase (69% homology in 206/296 AA,
region 1; Figure 4). B. breve UCC 2003 had an identical genomic
set-up to B. breve DSM 20213 (data not shown).
Coding Potential for Bifidobacteria Fucose
Utilization in Fecal Metagenomes
Bifidobacteria were the predominant taxa in feces of infants
from Venezuela, Malawi, and the USA during the first 2 years
of life based on 16S rRNA gene sequencing data (Figure 5).
For 111 samples, metagenomic data of the same donor data
were also available (Yatsunenko et al., 2012). Metagenomes were
screened for the presence of proteins presumably involved in
bifidobacterial L-fucose utilization (Figure 4). At the threshold
of detection allowed by sequencing coverage, the majority
of fecal metagenomes of infants under 2 years of all three
populations possessed the coding potential for bifidobacterial
fucose utilization (Figure 5). All infant metagenomes from
Venezuela (n = 11, 0.25–2 years) had coding potential for
bifidobacteria L-fucose utilization. Eighty-seven and Seventy-one
percent of proteins of both regions were recovered for B. longum
subsp. infantis and B. breve respectively; all infants were positive
for B. longum subsp. infantis while B. breve L-fucose utilization
was not detected in 1 infant. Similarly, all infant metagenomes
from Malawi (n = 18, 0.05–1.53 years) had coding potential for
bifidobacteria L-fucose utilization. On average, 93 and 74% of the
proteins of B. longum subsp. infantis and B. breve were detected,
respectively. Of the 44 fecal metagenomes of US American
infants (0.08–1.6 years), 16 and 28 were negative and positive for
bifidobacteria L-fucose utilization, respectively. B. breve assigned
proteins were detected in all children while B. longum subsp.
infantis L-fucose utilization related proteins were not detected in
one infant. The recovery of proteins of region 1 and 2 was 47
and 23% for B. longum subsp. infantis and B. breve, respectively.
Bifidobacterial L-fucose utilization related proteins were also
detected in feces of a 5 and a 6 year old US American child
(Figure 5).
DISCUSSION
E. hallii is a metabolically versatile species that can contribute
to intestinal butyrate and propionate formation (Duncan et al.,
2004; Engels et al., 2016). In adults, E. hallii is a regular
constituent of the gut microbiota (Engels et al., 2016). As shown
in this study, E. hallii persistently occurred in the first months
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FIGURE 4 | Genomic regions encompassing genes putatively involved in L-fucose degradation in B. longum and B. breve. The gene cluster of region 1
also contained genes encoding the α-fucosidases BLON_2335 and BLON_2336 and is part of the B. longum subsp. infantis HMO utilization operon H1 (adapted from
LoCascio et al., 2010; Bunesova et al., 2016 not drawn according to scale).
after birth at low abundance of the fecal microbiota and reached
adult levels at ∼5–10 years of age independent of geographical
donor origin. Thus, E. hallii is a commensal occurring very early
in life which might contribute to metabolic interactions starting
at 1–2 years of age when abundance markedly increased in all
populations.
B. breve and B. infantis subsp. longum were identified as
species capable of metabolizing fucose. Both are two of the most
representative species found in breast-milk fed infants (Avershina
et al., 2013; Matsuki et al., 2016), and fecal metagenome
analysis indicated the coding potential for bifidobacterial fucose
utilization in children under 2 years. Trophic interactions
of E. hallii and B. longum subsp. infantis and/or B. breve
during L-fucose and FL utilization can therefore be considered
infant specific (Figure 6). Interestingly, general occurrence and
the presence of bifidobacteria capable of L-fucose utilization
appeared to be higher in Venezuelan and Malawian than in
American infants. This might reflect differences in feeding
practice, as in Venezuela and Malawi, all analyzed infants below
2 years were breast-fed, while in the USA, 71% received formula
(Yatsunenko et al., 2012).
In the infant gut, E. hallii can utilize lactate and acetate
produced by bifidobacteria during the degradation of hexoses.
Bifidobacteria metabolize hexoses via the “bifid shunt” with
fructose-6-phosphoketolase as the key enzyme. Glucose (1 mol)
theoretically yields 1.5mol acetate, 1mol lactate, and 2.5 ATP
(de Vries and Stouthamer, 1967, 1968). However, this ratio
depends on whether the intermediate pyruvate is cleaved to
acetyl phosphate and formate, or whether it is reduced to lactate
(Palframan et al., 2003). B. longum subsp. infantis, B. longum
subsp. suis, and B. breve also metabolized the desoxyhexose
L-fucose. In mYCFA, nearly equimolar proportions of acetate,
formate and 1,2-PD and only little lactate were formed while in
API medium, lactate was produced at the expense of formate and
acetate. The ratio of acetate, formate, and lactate formed varies
for species, substrate source and carbohydrate supply (limitation
or excess; Macfarlane and Gibson, 1995; Palframan et al., 2003).
Here, ratios differed for the same species when supplied with
the same carbohydrate (30 mM L-fucose). In this study, mYCFA
was prepared strict anaerobically while API medium was only
facultative anaerobic, which could have also impacted pyruvate
metabolism. It was shown before that the presence of oxygen
changed final metabolites formed by B. longum subsp. infantis
(González et al., 2004).
Both bifidobacteria and E. hallii were able to produce formate
during the degradation of FL (Figure 6). Methanogens, which
can produce methane from formate and CO2, are usually
not detected in infants (Vanderhaeghen et al., 2015). As feces
collected as part of a cohort study following 16 infants from
2 weeks to 2 years of age (Pham et al., 2016, unpublished
data) contained no or only very low levels of formate, it
can be assumed that the formate produced during HMO
degradation is further utilized. Formate together with CO2
can also be used by acetogenic microbes such as Blautia
spp. to produce acetate via the Wood-Ljungdal pathway.
Little literature exists on formate cross-feeding within the
infant gut microbiota. However, as one of the important
intermediate metabolites, the effect of formate and formate
utilization on infant gut health should be investigated in further
studies.
We identified for the first time the ability of B. breve
strains to metabolize L-fucose to 1,2-PD. We previously
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FIGURE 5 | Relative abundance of the genus Bifidobacterium in infant
fecal samples. Relative abundance of Bifidobacterium in 16S rRNA gene
libraries of infant feces collected from Venezuela (A, n = 98), Malawi (B, n =
84), and USA (C, n = 307; Yatsunenko et al., 2012). For samples with
available metagenomes (Yatsunenko et al., 2012), the presence of genes
encoding bifidobacterial L-fucose utilization related proteins. Green symbols,
samples that were positive for bifidobacteria L-fucose utilization related
proteins, red symbols, samples that were negative, gray samples, no
metagenomes available.
suggested a Bifidobacterium L-fucose utilization pathway based
on genome comparison which has been also identified by a recent
study investigating FL degradation by a strain of B. longum
subsp. longum (Bunesova et al., 2016; Garrido et al., 2016).
Similar to strains of B. longum subsp. infantis and B. longum
subsp. suis, B. breve harbored two genomic regions which
encompassed genes putatively encoding enzymes involved in
L-fucose degradation with non-phosphorylated intermediates. In
contrast, the L-fucose-negative B. kashiwanohense only possessed
region 1 (Bunesova et al., 2016), suggesting that both regions
are necessary for L-fucose metabolism. In addition, two of
the identified genes encoding fucose permease (FucP) and
a 4-hydroxy-tetrahydrodipicolinate synthase, were upregulated
when B. breve was grown in co-culture with mucin degrading B.
bifidum (Egan et al., 2014). B. bifidum releases L-fucose during
growth with mucin similar to the release of fucose from FL
(Turroni et al., 2014; Garrido et al., 2015; Bunesova et al., 2016),
which then can be imported and metabolized by other species
such as B. breve or L-fucose-utilizing strains of B. longum.
In adults, B. adolescentis is a predominant Bifidobacterium
species, and cross-feeding between B. adolescentis and E. hallii
has been reported before (Belenguer et al., 2006). E. hallii was
thereby able to form butyrate from lactate and acetate that was
produced when B. adolescentis grew in the presence of starch, or
to use mono- or dissacharides released by B. adolescentis from
fructooligosaccharides. We also observed substrate-dependent
routes of metabolic cross-feeding. In the presence of L-fucose,
propionate was the main metabolite formed by E. hallii. In
co-cultures with B. longum subsp. infantis, the formation of
propionate, butyrate, and formate from FL was observed. Here,
butyrate and formate could have been produced from lactate and
acetate, or directly from glucose released by B. longum subsp.
infantis, while propionate again was derived from L-fucose.
FL is a major component of HMOs (de Leoz et al., 2012).
Therefore, it can be implied that a substantial proportion
of L-fucose is metabolized to propionate if E. hallii is
present. However, not all women are able to secrete α-(1-2)-
fucosylated HMOs due to mutations that render the responsible
fucosyltransferase FUT2 inactive. About 20% of the European
and African population carry an inactive FUT2 (Kelly et al.,
1995; Liu et al., 1998). The activity of FUT2 and with that the
presence of fucosylated HMOs has been linked to differences
in the establishment of the infant gut microbiota (Lewis et al.,
2015). The bifidobacteria community of infants born to non-
secretor mothers was reported to establish later, to carry reduced
numbers of bifidobacteria, and to contain a lower percentage of
bifidobacteria capable of degrading 2-FL compared to infants
of secretor mothers (Lewis et al., 2015). Thus, non-secretor
mothers’ milk lacks a significant source for intestinal propionate
formation. It could therefore be speculated that the SCFA profile
of infants of secretor- and non-secretor mothers is different.
However, to date, no large scale study compared the fecal SCFA
profile of infants born to secretor and non-secretor mothers.
Fucosylated oligosaccharides are not only a carbon source
for the intestinal microbes but also play an important role
in host-microbe interactions (Pickard et al., 2014). On one
hand, fucosylated HMOs protect against invasion of enteric
pathogens acting as a decoy for epithelial attachment sites
(Morrow et al., 2005). On the other hand, L-fucose released from
fucosylated oligosaccharides has been related to virulence and
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FIGURE 6 | Trophic interactions of L-fucose utilizing bifidobacteria and E. hallii during degradation of glucose, L-fucose or FL. Gray arrows indicate
glucose, L-fucose or FL derived degradation metabolites fed in the intestinal SCFA pool, black arrows indicate sugars or metabolites cross-fed between bifidobacteria
and E. hallii, blue arrows indicate metabolite formation.
host colonization of enteric pathogens. It was suggested that L-
fucose released by Bacteroides thetaiotamicron was utilized by
Salmonella enterica serovar Typhimurium during colonization
of a mouse model (Ng et al., 2013). Likewise, L-fucose
released by B. thetaiotamicron increased colonization of an
enterohaemorrhagic E. coli (EHEC) in comparison to mutants
with a knock-out of a fucose sensing two-component system
(Pacheco et al., 2012). This fucose sensing two-component
system regulates virulence and metabolic gene expression of
EHEC (Pacheco et al., 2012). The ability to utilize L-fucose
provided Campylobacter jejuni with a competitive advantage
during the colonization of birds or pigs compared to fucose-
negative mutants (Muraoka and Zhang, 2011; Stahl et al.,
2011). Through utilization of L-fucose, the infant bifidobacterial
community therefore could enhance colonization resistance
toward enteric pathogens.
CONCLUSION
L-fucose utilization was identified here as a trait of only
infant-derived bifidobacteria. Trophic interactions of
L-fucose-utilizing infant bifidobacteria and E. hallii yielded
different SCFAs from L-fucose or FL pointing at E. hallii
as a metabolically versatile species utilizing intermediate
metabolites of HMO fermentation. The utilization of L-fucose
by the infant bifidobacterial community might enhance
colonization resistance toward fucose-dependent enteric
pathogens.
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